MPLT

MapLight Therapeutics, Inc.$7.07-0.51 (-6.73%)

Prev Close$7.58·MCap$348.2M·P/E—·Vol91.1K·Yield—

▲

Buys (12M)

$693.8K

▼

Sells (12M)

$2.17M

◆

Net Activity

Net Seller

$1.48M

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at MapLight Therapeutics, Inc. (MPLT) has been dominated by selling, with 2 insider purchases totaling $693.8K and 10 insider sales totaling $2.17M. The most recent insider transaction was by Foff Erin Pennock (officer: Chief Medical Officer), who sold $124.1K worth of shares on Oct 16, 2026. MapLight Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $348.2M.

MPLT Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Oct 16, 2026	Foff Erin Pennock	officer: Chief Medical Officer	Sell	15,355	$8.08	$124.1K	296,906
Oct 16, 2026	Lillie James Woodruff	officer: Chief Scientific Officer	Sell	11,513	$8.08	$93.0K	198,597
Oct 16, 2026	Kroeger Christopher A.	director, officer: Chief Executive Officer	Sell	73,691	$8.08	$595.4K	1,195,909
Oct 16, 2026	GILLIS JONATHAN	officer: CAO and Interim CFO	Sell	10,167	$8.08	$82.1K	142,315
Oct 16, 2026	Hanson Kristopher	officer: General Counsel	Sell	9,020	$8.08	$72.9K	128,024
Oct 16, 2026	Kreitzer Anatol	officer: Chief Discovery Officer	Sell	12,248	$7.84	$96.0K	168,678
Feb 18, 2026	Pavlov George	Director	Buy	25,000	$17.65	$441.2K3.2% OS	0
Feb 13, 2026	Malenka Robert C.	Director	Sell	12,116	$18.21	$220.6K1.5% OS	0
Feb 12, 2026	Garnett Timothy John		Buy	14,124	$17.89	$252.7K1.8% OS	14,124
Feb 12, 2026	Malenka Robert C.		Sell	6,863	$18.12	$124.3K0.9% OS	351,611
Feb 4, 2026	Malenka Robert C.		Sell	7,040	$18.02	$126.9K0.9% OS	358,234
Jan 30, 2026	Malenka Robert C.		Sell	34,398	$18.49	$635.9K4.4% OS	393,811
Oct 30, 2025	Novo Holdings A/S		Buy	952,941	$17.00	$16.20M120.7% OS	3,686,622+35%
Oct 29, 2025	Catalyst4, Inc.		Buy	5,441,176	$17.00	$92.50M689.3% OS	19,697,464+38%

MPLT Insider Buying Activity

The following table shows recent insider purchases of MapLight Therapeutics, Inc. (MPLT) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Feb 18, 2026	Pavlov George	Director	Buy	25,000	$17.65	$441.2K3.2% OS	0
Feb 12, 2026	Garnett Timothy John		Buy	14,124	$17.89	$252.7K1.8% OS	14,124
Oct 30, 2025	Novo Holdings A/S		Buy	952,941	$17.00	$16.20M120.7% OS	3,686,622+35%
Oct 29, 2025	Catalyst4, Inc.		Buy	5,441,176	$17.00	$92.50M689.3% OS	19,697,464+38%

MPLT Insider Selling Activity

The following table shows recent insider sales of MapLight Therapeutics, Inc. (MPLT) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Oct 16, 2026	Foff Erin Pennock	officer: Chief Medical Officer	Sell	15,355	$8.08	$124.1K	296,906
Oct 16, 2026	Lillie James Woodruff	officer: Chief Scientific Officer	Sell	11,513	$8.08	$93.0K	198,597
Oct 16, 2026	Kroeger Christopher A.	director, officer: Chief Executive Officer	Sell	73,691	$8.08	$595.4K	1,195,909
Oct 16, 2026	GILLIS JONATHAN	officer: CAO and Interim CFO	Sell	10,167	$8.08	$82.1K	142,315
Oct 16, 2026	Hanson Kristopher	officer: General Counsel	Sell	9,020	$8.08	$72.9K	128,024
Oct 16, 2026	Kreitzer Anatol	officer: Chief Discovery Officer	Sell	12,248	$7.84	$96.0K	168,678
Feb 13, 2026	Malenka Robert C.	Director	Sell	12,116	$18.21	$220.6K1.5% OS	0
Feb 12, 2026	Malenka Robert C.		Sell	6,863	$18.12	$124.3K0.9% OS	351,611
Feb 4, 2026	Malenka Robert C.		Sell	7,040	$18.02	$126.9K0.9% OS	358,234
Jan 30, 2026	Malenka Robert C.		Sell	34,398	$18.49	$635.9K4.4% OS	393,811